Sean Bo­hen hauls in a mul­ti­mil­lion-dol­lar wind­fall as his new­ly adopt­ed biotech bags a $209M-plus IPO

Sean Bo­hen’s IPO for Ole­ma On­col­o­gy priced at $19 a share overnight, go­ing over the top of the range and giv­ing him an ini­tial mul­ti­mil­lion-dol­lar stake in the biotech as it ven­tures out in­to its first day of trad­ing on Thurs­day.

In their re­vised S-1 out a few days ago, the com­pa­ny did a re­verse split on his shares, leav­ing Bo­hen with an op­tion on 1,110,896 shares — about 3% of the com­pa­ny — at the re­con­fig­ured ex­er­cise price of $4.82. Those op­tions can be ex­er­cised with­in the next 40 days.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN